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Previewsidentified by Schnyder et al. in B cells play
an analogous role in T cells. And in both
systems, it will be important to continue
to define the molecular mechanisms that
control microcluster movement along the
microtubule network. But there are also
broader questions. The implication from
these papers is that signaling microclus-
ters generated in an actin-dependent
fashion in the periphery of the IS and
moved initially by actomyosin-dependent
forces transition to dynein-dependent
movement for final delivery into the center
of the IS. If so, how does this ‘‘hand-off’’
take place without an obvious change in
microcluster velocity or trajectory, and
why does depolymerization of actin fila-
ments result in loss of microcluster move-
ment, rather than enhanced dynein-
dependent movement? How does the
microtubule network contribute to the
supramolecular segregation of signaling
components? Clearly, current models in-voking differential actin binding or actin-
dependent clustering (Hartman et al.,
2009) must be revised. How do the two
filament systems work with respect to
plasma membrane-associated proteins
versus vesicle-associated molecules?
And finally, how are the actin andmicrotu-
bule networks coordinated? Based on
studies in nonhematopoietic cells (Eti-
enne-Manneville, 2004), it seems likely
that regulation of these two scaffolding
systems is intertwined, and that under-
standing this crosstalk will be essential
for understanding cytoskeletal control of
lymphocyte function.
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T follicular helper (Tfh) cells help B cells to generate affinity-matured antibodies. Three papers in this issue of
Immunity (Choi et al., 2011; Kerfoot et al., 2011; Kitano et al., 2011) provide information about the reciprocal
relationship between B cells and Tfh cells.It was reported more than two decades
ago that T cell clonal expansion in lymph
nodes (LN) was impaired in mice made
deficient in B cells by continuous injec-
tions of antibodies directed against the
heavy chain from birth (Ron and Sprent,
1987). Like other T cells, B cells are crucial
for the development of a specialized
subset of CD4+ T helper cells known as
T follicular helper (Tfh) cells (Haynes
et al., 2007). The relationship between
Tfh cells and B cells is thought to be
especially important because of a recip-
rocal dependency played out during thegeneration of affinity-matured antibody.
This cognate interaction occurs in spe-
cialized, temporary structures, termed
germinal center (GC) reactions, that form
within B cell follicles of secondary
lymphoid organs after infection or immu-
nization with nonreplicating T cell-depen-
dent antigen.
GC B cells require T cell help to
produce affinity-matured antibody. More
recently, however, evidence has been
presented to show that this dependence
is not reciprocal because Tfh cells can
develop without B cells, provided thatthe T cells get adequate stimulation from
peptide antigen-MHCII complexes dis-
played on other antigen-presenting cells
(APCs) (Deenick et al., 2010). This finding
indicated that the role of B cells may
reflect their ability to provide an ample
source of antigen to Tfh cells and ques-
tioned whether B cells provide any unique
signals. Which antigen-presenting cells
Tfh cells interact with at different points
during their activation is explored in
detail in three papers in the current issue
of Immunity (Choi et al., 2011; Kerfoot
et al., 2011; Kitano et al., 2011). One clear34, June 24, 2011 ª2011 Elsevier Inc. 827
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Figure 1. Differentiation and Maintenance of Follicular Helper T Cells by Antigen-Presenting Cells
Upon activation of naive CD4+ T cells by peptideMHC class II complexes on antigen-presenting cells (APCs) (most probably dendritic cells [DCs]), inducible T cell
costimulator (ICOS), programmed cell death 1 (PD-1), the transcriptional repressor B cell lymphoma 6 (Bcl-6), and the chemokine receptor CXCR5 are upregu-
latedwithin the first 3 days of exposure to antigen. The costimulatory molecule ICOS and coinhibitory molecule PD-1 expressed on CD4+ T cells are the receptors
for ICOSL and PD-L1 (or PD-L2) expressed on APCs. By day 4, antigen-experienced B cells become crucial APCs for T helper cells and the cognate interaction
with B cells sustain T follicular helper (Tfh) cells with high expression of Bcl-6 and high surface density of ICOS, PD-1, and CXCR5.
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Previewsconsensus is that although B cells are
dispensable for the priming of CD4+
T cells and initial acquisition of a Tfh cell
phenotype, they are important for the
maintenance and function of Tfh cells
during the GC reaction (Figure 1).
T and B cells are distinctly compart-
mentalized within secondary lymphoid
tissues and dynamic changes in lympho-
cyte migration occur during immune
responses that facilitate the chance of
contact between rare antigen-experi-
enced B cells and T helper cells. Placing
Tfh cells in an in vivo context via immuno-
histology and intravital approaches,
Kitano et al. (2011) and Kerfoot et al.
(2011) visualized early events in the B
cell follicle and intrafollicular (IF) zone
providing important temporal and spatial
information about the early progression
toward a Tfh cell phenotype and a GC B
cell phenotype. Several recent studies
have shown thatmacrophages positioned
at the subcapsular sinus (SCS) acquire
antigen that is presented to B cells that
then migrate into the B cell follicle (Cyster,
2010). However, in the study by Kerfoot
et al. (2011), a trend of movement of
B cells from the SCS into the follicular
interior was not discerned, and whether
this reflected the form of antigen or other
aspects of the experimental system will
be the subject of future studies.
Characteristically, Tfh cells express
high amounts of the CXC-chemokine828 Immunity 34, June 24, 2011 ª2011 Elsevreceptor 5 (CXCR5) on their surfaces
and lose expression of CCR7, which
directs these cells toward CXCL13-rich
follicular dendritic cells within GC.
However, previous studies have shown
that the expression of CXCR5 is tran-
siently upregulated when CD4+ T cells
interact with peptide-MHC class II and
costimulatory molecules on APCs (King
et al., 2008). Similarly, the expression of
the inducible T cell costimulator (ICOS)
and the coinhibitory molecule, pro-
grammed cell death 1 (PD-1), both used
to detect Tfh cells, are common to
recently activated CD4+ T cells. Examina-
tion of the kinetics of expression of these
molecules extends the list of Tfh cell
markers that are broadly expressed on
CD4+ T cells within 3 days of antigen
administration to include GL7 and the
transcriptional repressor B cell lymphoma
6 (Bcl-6) (Choi et al., 2011; Kerfoot et al.,
2011; Kitano et al., 2011). This informa-
tion, gained from detailed kinetic analyses
of the development of Tfh cells during
immune responses, demonstrates that
the initial interaction of CD4+ T cells with
dendritic cells provides the stimulus for
the upregulation of CXCR5, ICOS, PD-1,
GL7, and Bcl-6 (Figure 1; Choi et al.,
2011; Kerfoot et al., 2011; Kitano et al.,
2011). Indeed, these ‘‘Tfh cell phenotypic
markers’’ described the majority of
antigen-specific CD4+ T cells 2 days after
immunization (Kerfoot et al., 2011). Byier Inc.contrast, 8 days after immunization, in
the mature GC, PD-1hiCXCR5hi Tfh cells
were clearly distinguished (Kerfoot et al.,
2011).
In each of these studies, the stimulus
required to sustain these molecules on
CD4+ T cells was provided by cognate
interactions with B cells (Choi et al.,
2011; Kerfoot et al., 2011; Kitano et al.,
2011). Indeed, by day 4 of immunization
in the absence of cognate B cells, cells
expressing a Tfh cell phenotype were
lost (Choi et al., 2011). Although there
were markedly less Tfh phenotype cells
in the absence of B cells, they did migrate
into the B cell follicle (Kerfoot et al., 2011).
This observation begs the question of
whether there was a functional difference
between Tfh cells that develop in the
presence or absence of B cells. Impor-
tantly, Tfh cells that developed in the
absence of B cells were functionally
impaired with reduced IL-4 and IL-21
(Kerfoot et al., 2011). One caveat (noted
by the investigators) is that the use of B
cells with a fixed BCR receptor affinity
toward the antigen and antigen-specific
TCR transgenic T cells might influence
the kinetics and fate commitments of the
response (Choi et al., 2011; Kerfoot
et al., 2011; Kitano et al., 2011). It was
therefore satisfying to observe that the
expression of Tfh cell molecules similarly
emerged 3 days after LCMV infection
(Choi et al., 2011).
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PreviewsTfh cells require strong signals through
the antigen receptor and costimulation
in the form of cell surface molecules and
cytokine growth factors (King et al.,
2008). However, increased responsive-
ness to IL-2 does not appear to be crucial
for Tfh cell differentiation or survival as
evidenced by the segregated expression
of Bcl-6 and the a chain of the high-affinity
IL-2 receptor (Choi et al., 2011). Whether
this reinforces their differential expression
of the B lymphocyte-induced maturation
protein 1 (Blimp) and Bcl-6 remains to
be determined. The mechanisms explain-
ing the regulation of Bcl-6 remain largely
unknown, but the induction of Bcl-6 in
CD4+ T cells requires ICOS (Choi et al.,
2011). Furthermore, ICOS induction of
Bcl-6 expression was observed to
sequentially induce CXCR5 expression
prior to the involvement of B cells (Choi
et al., 2011). Utilizing a reporter mouse
strain generated to track Bcl-6 protein
expression in vivo, Kitano et al. (2011)
observed that upregulation of Bcl-6
protein in antigen-engaged CD4+ T cells
preceded that of antigen-engagedB cells.
Marked heterogeneity was observed in
the expression of Bcl-6 in Tfh phenotype
cells (Kerfoot et al., 2011; Kitano et al.,
2011), yet these new studies concur with
previous studies showing that CD4+
T cells further upregulated Bcl-6 expres-
sion through cognate interactions with B
cells (Poholek et al., 2010).
Interestingly, Bcl-6 protein was gradu-
ally lost in Tfh cells whereas Bcl-6 protein
was maintained in GC B cells (Kitano
et al., 2011). After downregulation of
Bcl-6, Tfh cells decreased proliferation
and increased expression of the a chain
of the receptor for IL-7. However, despite
the loss of Bcl-6 protein, the expression of
the gene for Blimp1, positive regulatorydomain I (Prdm1), remained low in Bcl-
6lo Tfh cells and mRNA transcript for
Bcl-6 remained high (Kitano et al., 2011).
The basis for these interesting findings
will require clarification and the influence
of one potentially defective Bcl6 allele in
the heterozygous reporter cells remains
unknown. Extended temporal analyses
will be needed to analyze the population
of Bcl-6lo Tfh cells. Whether the Tfh cells
that downregulate Bcl-6 have the poten-
tial to redirect their differentiation into
other Th cell subsets, stay in the GC as
memory phenotype Tfh cells (Fazilleau
et al., 2007), or join the circulating pool
of CXCR5+CD4+ memory T cells will be
the focus of future studies.
Thus, Tfh cells uniquely receive con-
tinued stimulation through their antigen
receptors beyond the time when effector
CD4+ T cells have migrated out of the
lymphoid organ and the local CD4+ T cell
response has begun to contract. In this
context, Tfh cells appear to become
transfixed in an activated phenotype
maintained by high expression of the tran-
scriptional repressor Bcl-6, which is
consistent with their original description
as an activated, nonpolarized subset
(King et al., 2008). Like all interesting
work, these recent studies raise many
questions. The term ‘‘maintenance’’ of
Tfh cells is used extensively in these three
studies (Choi et al., 2011; Kerfoot et al.,
2011; Kitano et al., 2011), but what main-
tenance actually means remains enig-
matic. B cells may be important for
the continued clonal expansion of Tfh
phenotype cells, as shown by the prolifer-
ation of Bcl-6-expressing T cells in the
presence of cognate B cells (Kitano
et al., 2011), or B cells may be required
to sustain features of the Tfh cell pheno-
type. Alternatively, B cells may be impor-Immunitytant for the survival of Tfh cells—a possi-
bility that is supported by the increased
numbers of Tfh cells observed within
B cell follicles in the presence of cognate
B cells on days 4 and 8 after immunization
(Kerfoot et al., 2011). Efforts to define the
mechanism(s) explaining how B cells
support Tfh cells will continue to generate
research within this exciting field. Collec-
tively, these new studies provide a kinetic
framework for Tfh cell development that
advance our understanding of immune
responses and will be valuable for
improved vaccine design.
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